Business Context and Reporting Period
This Form 8-K is a current report filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on June 23, 2017, regarding an event that occurred on June 20, 2017. The filing addresses a change in senior management.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The material change reported is the resignation of Thomas B. Miller as Chief Financial Officer (CFO). Mr. Miller is departing to pursue other opportunities. The departure was not the result of any disagreement with the Company regarding operations, policies, or practices.
Outlook and Management Commentary
- Transition Plan: Mr. Miller agreed to remain in his role until the Company announces its second-quarter results and files the Form 10-Q for the period ending June 30, 2017.
- Succession: The Company has commenced an executive search to identify a suitable replacement for the CFO role.
- Risks: No specific financial risks or contingencies were disclosed in this filing.
Investor Verification Checklist
- Verify the timeline for the appointment of a new Chief Financial Officer.
- Review the upcoming Form 10-Q for the period ended June 30, 2017, for financial performance details.
- Confirm that the departure of the CFO does not impact the accuracy or timing of the Q2 earnings release.